RAPP — Rapport Therapeutics

Median target
$59
calls from the last 12 months
Implied return
+131.9%
median target vs. price
Coverage
11 analysts · 12 calls
updated in the last 12 months
Consensus
11/0/0+11 net
Buy / Hold / Sell

Which analysts are behind RAPP's consensus?

See every current rating, price target and the analysts' track records for Rapport Therapeutics — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 11 analysts with calls on RAPP updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

RAPP elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-10-28InsidersHealy JamesDirectorInsider purchase952.4K sh @ $21.00$20.0M
2026-10-28InsidersHealy JamesDirectorInsider purchase6.9K sh @ $21.00$146K
2026-10-28InsidersHealy JamesDirectorInsider purchase6.4K sh @ $21.00$134K
2026-10-28InsidersHealy JamesDirectorInsider purchase3.8K sh @ $21.00$79K
2026-10-23InsidersSanchez RamiroDirectorInsider purchase3.6K sh @ $27.35$98K
2026-10-22InsidersPaul Steven MDirectorInsider purchase35.7K sh @ $27.28$974K
2026-10-22InsidersMaraganore JohnDirectorInsider purchase8.2K sh @ $26.38$217K
2026-10-22InsidersYoung Wendy B.DirectorInsider purchase3.8K sh @ $26.39$100K
2026-10-22InsidersSilva Paul MDirectorInsider purchase3.7K sh @ $27.07$100K
2026-10-22InsidersMaraganore JohnDirectorInsider purchase1.2K sh @ $26.92$32K

More: insider activity · executive branch · trending